ABSTRACT
Introduction of antiretroviral therapy (ART) has dramatically reduced the incidence of infectious ocular diseases in human immunodeficiency virus (HIV)-infected individuals. However, the effects of long-term ART and chronic HIV infection on the eye are ill-defined. This study determined the occurrence and severity of ocular diseases among 342 participants in a rural South African setting: HIV-naïve (n = 105), HIV-infected ART-naïve (n = 16), HIV-infected on ART for 36 months (long-term ART; n = 165). More HIV-infected participants presented with an external eye condition, in particular blepharitis, than HIV-naïve individuals (18% vs. 7%; age-adjusted odds ratio (aOR) = 2·8, P < 0·05). Anterior segment conditions (particularly keratoconjunctivitis sicca and pterygium) were also more common (50% vs. 27%; aOR = 2·4; P < 0·01). Compared with individuals on short-term ART, participants receiving long-term ART were more likely to have clinically detectable cataract (57% vs. 38%; aOR = 2·2, P = 0·01) and posterior segment diseases, especially HIV retinopathy (30% vs. 11%; aOR = 3·4, P < 0·05). Finally, long-term ART was significantly associated with presence of HIV retinopathy (P < 0·01). These data implicate that ocular disease is more common and of more diverse etiology among HIV-infected individuals, especially those on long-term ART and suggest that regular ophthalmological monitoring of HIV-infected individuals on ART is warranted.
Subject(s)
Anti-Retroviral Agents/administration & dosage , Eye Diseases/epidemiology , HIV Infections/drug therapy , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Odds Ratio , Risk Factors , Rural Population , South Africa/epidemiology , Young AdultABSTRACT
There is a paucity of data on the immune reconstitution inflammatory syndrome (IRIS) in the Central African region. We followed ART-naive HIV-infected patients initiating antiretroviral therapy in an HIV clinic in Gabon, for 6 months. Among 101 patients, IRIS was diagnosed in five. All IRIS cases were mucocutaneous manifestations. There were no cases of tuberculosis (TB) IRIS, but active TB (n = 20) was associated with developing other forms of IRIS (p = 0.02). Six patients died. The incidence of IRIS is low in Gabon, with mild, mucocutaneous manifestations.
Subject(s)
Anti-Retroviral Agents/adverse effects , HIV Infections/drug therapy , Immune Reconstitution Inflammatory Syndrome/epidemiology , Adult , Female , Gabon/epidemiology , Humans , Immune Reconstitution Inflammatory Syndrome/chemically induced , Immune Reconstitution Inflammatory Syndrome/etiology , Immune Reconstitution Inflammatory Syndrome/immunology , Incidence , Male , Middle Aged , Prospective Studies , Tuberculosis/complicationsABSTRACT
The purpose of this investigation was to determine the clinical and corneal microbial profile of infectious keratitis in a high human immunodeficiency virus (HIV) prevalence setting in rural South Africa. Data in this cross-sectional study were collected from patients presenting with symptoms of infectious keratitis (n = 46) at the ophthalmology outpatient department of three hospitals in rural South Africa. Corneal swabs were tested for herpes simplex virus type 1 (HSV-1) and 2 (HSV-2), varicella zoster virus (VZV) and adenovirus DNA by real-time polymerase chain reaction (PCR) and for bacteria and fungi by culture. Based on clinical history, disease characteristics and laboratory results, 29 (63 %) patients were diagnosed as viral keratitis, including 14 (48 %) viral keratitis cases complicated by bacterial superinfection, and 17 (37 %) as bacterial keratitis. VZV and HSV-1 DNA was detected in 11 (24 %) and 5 (11 %) corneal swabs, respectively. Among clinically defined viral keratitis cases, a negative viral swab was predominantly (93 %) observed in cases with subepithelial inflammation and was significantly associated with an increased duration of symptoms (p = 0.003). The majority of bacteria cultured were Gram-positive (24/35), including Staphylococcus epidermidis and S. aureus. Viral aetiology was significantly associated with a history of herpes zoster ophthalmicus (p < 0.001) and a trend was observed between viral aetiology and HIV infection (p = 0.06). Twenty-one (47 %) keratitis cases were complicated by anterior uveitis, of which 18 (86 %) were HIV-infected cases with viral keratitis. The data implicate a high prevalence of herpetic keratitis, in part complicated by bacterial superinfection and/or uveitis, in HIV-infected individuals presenting with infectious keratitis in rural South Africa.
Subject(s)
Bacteria/isolation & purification , Cornea/microbiology , Cornea/virology , Fungi/isolation & purification , Keratoconjunctivitis, Infectious/microbiology , Keratoconjunctivitis, Infectious/virology , Viruses/isolation & purification , Adolescent , Adult , Aged , Aged, 80 and over , Animals , Bacteria/classification , Bacteriological Techniques , Cross-Sectional Studies , DNA, Viral/genetics , DNA, Viral/isolation & purification , Female , Fungi/classification , HIV Infections/complications , HIV Infections/epidemiology , Humans , Keratoconjunctivitis, Infectious/epidemiology , Male , Middle Aged , Prevalence , Rural Population , South Africa/epidemiology , Viruses/classification , Young AdultABSTRACT
A 26-year-old male patient had been suffering from a decreased visual acuity in both eyes for 3 weeks. This appeared to be due to malignant hypertension. The hypertension went unnoticed until papillary and macular oedema were detected during fundoscopy. Hypertension can develop at all ages and may give rise to visual complaints or even to loss of vision. Insufficient clinical awareness of the atypical manifestations of severe hypertension and of the differential diagnosis of loss of vision may lead to irreversible damage of organs, in this patient the left eye. Fundoscopy is sometimes indicated in patients with severe hypertension to assess damage to the eye and to decide whether the patient must be hospitalised.
Subject(s)
Hypertension, Malignant/complications , Vision Disorders/etiology , Adult , Humans , Hypertension, Malignant/diagnosis , Male , Vision Disorders/diagnosisABSTRACT
This article describes a 7-month-old infant with posterior scleritis, diagnosed on the basis of B-scan ultrasonography and computed tomography. The patient was initially diagnosed with preseptal cellulitis and endophthalmitis. Posterior scleritis should be considered in the differential diagnosis of acute orbital inflammation in children younger than 1 year.
Subject(s)
Scleritis/diagnosis , Anti-Bacterial Agents/therapeutic use , Diagnosis, Differential , Drug Therapy, Combination , Endophthalmitis/diagnosis , Follow-Up Studies , Glucocorticoids/therapeutic use , Humans , Infant , Sclera/diagnostic imaging , Scleritis/drug therapy , Tomography, X-Ray Computed , UltrasonographySubject(s)
Acute Kidney Injury/pathology , Eye Diseases/pathology , Leptospirosis/complications , Acute Kidney Injury/diagnostic imaging , Adolescent , Agglutination Tests , Eye Diseases/etiology , Humans , Kidney/pathology , Leptospira/immunology , Leptospirosis/microbiology , Leptospirosis/pathology , Male , Sports , Ultrasonography , Uveitis/etiologyABSTRACT
Fomivirsen is a 21-nucleotide phosphorothioate oligonucleotide which, when injected into a human eye, is capable of inhibiting CMV retinitis. Its mode of action is consistent with an antisense mechanism. Prior to human trials, fomivirsen was tested in a number of in vitro cell lines and was found to inhibit CMV replication in a dose-dependent manner with a mean 50% inhibitory concentration between 0.03 and 0.2 microM. Intravitreal drug clearance studies have revealed first-order kinetics with a half-life in the rabbit of 62 hours. In a clinical trial of patients with newly diagnosed CMV retinitis receiving 165 mg per injection, time to progression was interpolated to 71 days with 44% of the patients remaining on treatment for over one year. In patients who failed other anti-CMV treatments, the interpolated time to progression was 91 days when receiving 330 mg per injection. No systemic absorption of the drug could be detected. Reported adverse events have been for the most part mild to moderate in intensity and either resolved spontaneously or were treatable with topical medications. Locally administered fomivirsen effectively inhibits CMV retinitis using a mode of action which is complementary to existing DNA polymerase inhibitors.
Subject(s)
Antiviral Agents/therapeutic use , Cytomegalovirus Infections/drug therapy , Retinitis/virology , Thionucleotides/therapeutic use , Clinical Trials, Phase III as Topic , Cytomegalovirus Infections/physiopathology , Disease Progression , Eye/drug effects , Humans , Oligonucleotides, Antisense/therapeutic use , Thionucleotides/adverse effects , Time FactorsSubject(s)
Toxoplasmosis, Congenital/diagnosis , Toxoplasmosis, Congenital/drug therapy , Adult , Animals , Anti-Bacterial Agents/therapeutic use , Antiprotozoal Agents/therapeutic use , Child , Female , Follow-Up Studies , Humans , Male , Middle Aged , Pyrimethamine/therapeutic use , Secondary Prevention , Spiramycin/therapeutic use , Sulfadiazine/therapeutic use , Time FactorsABSTRACT
OBJECTIVE: To investigate possible differences in cytomegalovirus (CMV) strain distribution between the eye and blood in AIDS patients with CMV retinitis. METHODS: CMV DNA sequences from aqueous humour and peripheral blood leukocytes (PBL), obtained from 13 AIDS patients with CMV retinitis, were compared. DNA was isolated and the CMV IE-1 sequence (part of the immediate early-1 gene) and the a-sequence (located in the a-region) were amplified by polymerase chain reaction (PCR). The PCR products of the a-sequence were analysed by Southern blotting for amplified fragment-length polymorphisms. The level of divergence between the a-sequences of aqueous humour- and PBL-derived CMV was studied in two patients by cloning these sequences followed by sequence analysis. RESULTS: CMV DNA could be detected in all aqueous humour samples and in 10 out of 13 paired blood samples. In the 10 patients, with CMV DNA detectable in both aqueous humour and PBL, seven cases showed differences between the amplified products of both compartments. Sequence analysis in two patients revealed that the aqueous humour and PBL of the same patient can harbour both identical, similar and highly divergent CMV a-sequences. CONCLUSION: These results indicate that despite the haematogenous spread of CMV, the eye, being a relatively shielded organ, may contain CMV strains different from those found in the blood.
Subject(s)
AIDS-Related Opportunistic Infections/virology , Cytomegalovirus Retinitis/virology , Cytomegalovirus/genetics , Eye/virology , Immediate-Early Proteins/genetics , Viral Proteins , AIDS-Related Opportunistic Infections/blood , Adult , Base Sequence , Cytomegalovirus/isolation & purification , Cytomegalovirus Retinitis/blood , DNA, Viral , Eye/pathology , Humans , Male , Middle Aged , Molecular Sequence Data , Sequence Homology, Nucleic AcidABSTRACT
We report on a 29-year-old severely compromised acquired immunodeficiency syndrome patient who developed retrobulbar optic neuritis 5 weeks after an episode of cutaneous herpes zoster infection. During the optic neuritis, varicella zoster virus could be demonstrated in the cerebrospinal fluid. The neuritis responded well to treatment with foscarnet, but, 3 weeks into therapy, varicella zoster retinitis developed. Additional treatment with intravenous acyclovir stopped progression of the retinitis and resulted in healing of the retinal lesions. This case suggests that retrobulbar optic neuritis can be regarded as a prodrome of imminent acute retinal necrosis. Early recognition and prompt therapy with combined antivirals may prevent the development of this devastating ocular complication of varicella zoster infection.
Subject(s)
AIDS-Related Opportunistic Infections/virology , Acquired Immunodeficiency Syndrome/complications , Herpes Zoster Ophthalmicus/complications , Herpes Zoster/complications , Herpesvirus 3, Human , Optic Neuritis/etiology , Acyclovir/therapeutic use , Adult , Antiviral Agents/therapeutic use , Female , Foscarnet/therapeutic use , Herpes Zoster/drug therapy , Herpes Zoster Ophthalmicus/drug therapy , Herpes Zoster Ophthalmicus/pathology , Humans , Male , Optic Neuritis/virology , Visual AcuityABSTRACT
AIM: To gain insight into the course of CMV retinitis (CMVR) in AIDS patients receiving protease inhibitors (PI), and to evaluate whether certain patterns of CD4 response are indicative of the clinical outcome and the risk of recurrence. METHODS: 15 consecutive AIDS patients receiving maintenance therapy for CMVR were included in a prospective observational cohort study at the university hospital between July and October 1996. Patients were evaluated for signs of CMVR activity and intraocular inflammation. CMVR recurrence was defined as the primary clinical endpoint. Follow up was performed until July 1997. No patient was lost to follow up. Clinical outcome was related to CD4+ lymphocyte counts, which were monitored every 6 weeks. Highly active antiretroviral treatment regimen including PI was started at study entry. RESULTS: All recurrences (n = 7) were in patients who failed to have a sustained increase in CD4 counts, whereas CMVR remained inactive during a follow up of 42-52 weeks in those who were able permanently to restore their CD4 values to 100 x 10(6)/l or more (n = 5). The remaining three patients died after 12, 16, and 50 weeks, respectively, without recurrences. All relapses of CMVR were seen after 6-16 weeks, and at CD4 counts well below 100 x 10(6)/l. CONCLUSIONS: The beneficial effects of PI treatment correlate with the pattern of CD4 response. Sustained increases in CD4 counts achieved in the first 16 weeks of treatment are associated with a prolonged period of CMVR quiescence. Poor initial response is associated with a high risk of CMVR recurrence.
Subject(s)
AIDS-Related Opportunistic Infections/drug therapy , Anti-HIV Agents/therapeutic use , CD4-Positive T-Lymphocytes/drug effects , Cytomegalovirus Retinitis/drug therapy , HIV Protease Inhibitors/therapeutic use , AIDS-Related Opportunistic Infections/immunology , CD4 Lymphocyte Count/drug effects , CD4-Positive T-Lymphocytes/immunology , Cytomegalovirus Retinitis/immunology , Disease Progression , Follow-Up Studies , HIV Infections/drug therapy , HIV Infections/immunology , Humans , Prospective Studies , Recurrence , Vitreous BodyABSTRACT
BACKGROUND: A patient with AIDS who developed the clinical picture of bilateral progressive outer retinal necrosis (PORN) in combination with varicella zoster encephalitis is described. The picture developed more than 2 years after an episode of ophthalmic zoster infection, and following intermittent exposure to oral acyclovir because of recurrent episodes of cutaneous herpes simplex infection. METHODS: Aqueous humour, obtained by paracentesis of the anterior chamber, was analysed using immunofluorescence and polymerase chain reaction (PCR). Postmortem analysis of eye and brain tissue was performed by using conventional techniques and in situ hybridisation. RESULTS: While conventional techniques all failed to detect a causative agent, analysis of the aqueous humour using PCR, and histological examination of necropsy specimens from eyes and brain using in situ hybridisation were conclusive for the diagnosis varicella zoster virus (VZV) infection. CONCLUSION: This case documents the presumed association of PORN and VZV encephalitis in a severely immunocompromised AIDS patient.
Subject(s)
AIDS-Related Opportunistic Infections/complications , Encephalitis, Viral/complications , Herpes Zoster/complications , Retinal Diseases/complications , Acyclovir/therapeutic use , Adult , Antiviral Agents/therapeutic use , Encephalitis, Viral/diagnosis , Herpes Simplex/drug therapy , Herpes Zoster/drug therapy , Humans , In Situ Hybridization , Male , Necrosis , Polymerase Chain Reaction , Retinal Diseases/drug therapy , Retinal Diseases/virologyABSTRACT
PURPOSE: Outcomes of HLA-B27-positive and HLA-B27-negative acute anterior uveitis were assessed after a mean follow-up of nine years. Rheumatologic complications, in particular the presence and course of ankylosing spondylitis, were examined during the same period. METHODS: A hospital-based prospective study of 119 patients with HLA-B27-positive and 35 patients with HLA-B27-negative acute anterior uveitis was performed. All patients underwent a complete ophthalmologic and rheumatologic examination, including sacroiliac x-rays, and were examined again nine years later. RESULTS: No statistically significant differences in ocular complications and visual outcome were found between both patient groups with acute anterior uveitis after nine years. Posterior synechiae were observed in one half of the affected eyes. Blindness was infrequent. Rheumatologic complications, including ankylosing spondylitis, originally seen in one half of the HLA-B27-positive patients, were observed in two thirds of the patients nine years later, compared to only two of 35 HLA-B27-negative patients. When ankylosing spondylitis was evident at first examination no clinically significant deterioration was observed nine years later. CONCLUSIONS: After nine years we observed an ocular outcome equal for both patient groups. A small percentage of affected eyes became blind. Rheumatologic complications occurred in 55 (72%) of 76 HLA-B27-positive males and in 24 (56%) of 43 HLA-B27-positive females with acute anterior uveitis. The rheumatologic complications had a good prognosis.
Subject(s)
HLA-B27 Antigen , Spondylitis, Ankylosing/complications , Uveitis, Anterior/complications , Acute Disease , Adolescent , Adult , Aged , Blindness/etiology , Child , Eye Diseases/etiology , Female , Follow-Up Studies , Humans , Male , Middle Aged , Prognosis , Prospective Studies , Uveitis, Anterior/immunology , Visual AcuityABSTRACT
AIMS: This study was set up to determine the long term ocular and systemic sequelae in patients with severe congenital toxoplasmosis. METHODS: Cross sectional and retrospective study of 17 patients with severe congenital toxoplasmosis. RESULTS: In addition to chorioretinitis (100%), the most common abnormal ocular features were optic nerve atrophy (83%), visual acuity of less than 0.1 (85%), strabismus, and microphthalmos. In 50% of cases we observed iridic abnormalities and about 40% developed a cataract. Overt endocrinological disease, diagnosed in five of 15 patients, included panhypopituitarism (n = 2), gonadal failure with dwarfism (n = 1), precocious puberty with dwarfism and thyroid deficiency (n = 1), and diabetes mellitus and thyroid deficiency (n = 1). The observed endocrinological involvement was associated in all cases with obstructive hydrocephalus with a dilated third ventricle and optic nerve atrophy. CONCLUSION: The recognition of long term ocular, neurological, and endocrinological sequelae of congenital toxoplasmosis is important for medical management of these severely handicapped patients.
Subject(s)
Toxoplasmosis, Cerebral/congenital , Toxoplasmosis, Ocular/congenital , Adolescent , Adult , Chorioretinitis/etiology , Cross-Sectional Studies , Endocrine System Diseases/etiology , Female , Humans , Hydrocephalus/etiology , Male , Microphthalmos/etiology , Optic Atrophy/etiology , Retrospective Studies , Strabismus/etiology , Toxoplasmosis, Cerebral/complications , Toxoplasmosis, Ocular/complications , Visual AcuityABSTRACT
HLA-A, HLA-B, HLA-C, and HLA-D typing was performed in 47 mothers of patients suffering from ocular toxoplasmosis to investigate whether an immunogenetic predisposition exists for developing congenital toxoplasmosis in their offspring. No significant association between any HLA antigen was observed in the mothers of patients with ocular toxoplasmosis, although a total absence of the HLA-B51 antigen was found in this group. HLA-A, HLA-B, and HLA-C typing was also performed in their children (52 patients with ocular toxoplasmosis), to investigate a possible relation between the severity of ocular toxoplasmosis and an eventual immunogenetic factor. In the patients with ocular toxoplasmosis an increased frequency of the HLA-Bw62 antigen was observed in correlation with severe ocular involvement.
Subject(s)
Histocompatibility Testing , Toxoplasmosis, Congenital/immunology , Toxoplasmosis, Ocular/immunology , Disease Susceptibility , Female , HLA-A Antigens , HLA-B Antigens , HLA-B15 Antigen , HLA-B51 Antigen , HLA-B7 Antigen , Humans , Infant, Newborn , Infectious Disease Transmission, Vertical , Risk , Toxoplasmosis, Ocular/transmissionABSTRACT
We conducted a prospective multicenter study of the efficacy of current therapeutic strategies for ocular toxoplasmosis in 149 patients. Treatment consisted of the following three triple-drug combinations: group 1, pyrimethamine, sulfadiazine, and corticosteroids; group 2, clindamycin, sulfadiazine, and corticosteroids; and group 3, trimethoprim, sulfamethoxazole and corticosteroids. Patients with peripheral retinal lesions were not treated systemically. No difference in the duration of inflammatory activity was observed between treated and untreated patients (P = .5). The most important factor predicting the duration of inflammatory activity was the size of the retinal lesion itself, independent of the treatment (P < .001). We found a reduction in size of the retinal inflammatory lesion for 49% of the pyrimethamine-treated patients (17 of 35) compared to 20% of the untreated patients (eight of 41) (P < .01). However, the most frequent occurrence of side effects was also associated with pyrimethamine medication (26%, nine of 35). The mean recurrence rate after three years of follow-up was 49% for all patients (60 of 122 patients), with no differences between treated and untreated patients (P = .6).
Subject(s)
Chorioretinitis/drug therapy , Toxoplasmosis, Ocular/drug therapy , Adult , Chorioretinitis/parasitology , Clindamycin/therapeutic use , Drug Therapy, Combination , Female , Follow-Up Studies , Glucocorticoids/adverse effects , Glucocorticoids/therapeutic use , Humans , Male , Prospective Studies , Pyrimethamine/adverse effects , Pyrimethamine/therapeutic use , Recurrence , Sulfadiazine/adverse effects , Sulfadiazine/therapeutic use , Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic useABSTRACT
Ocular toxoplasmosis, a leading cause of visual handicaps in young people, represents a late manifestation of congenital infection in the majority of cases. Ocular involvement in acquired toxoplasmosis has been repeatedly reported and shows that toxoplasmic retinitis may develop in the wake of acquired infection. The diagnosis of ocular toxoplasmosis is mainly clinical since serologic tests are positive for a considerable percentage of the general population and are not indicative for ocular involvement. The demonstration of local synthesis of toxoplasma antibodies in the eye by intraocular fluid analysis is a valuable diagnostic tool. The application of the polymerase chain reaction, in which the parasite's DNA is detected, may be expected to change the diagnostic repertoire drastically in the future. The need for appropriate therapy for patients with ocular toxoplasmosis is a matter of continued debate: the majority of the medications used for treatment have potentially serious side effects and the efficacy of treatments has not been clarified in previous studies. Recently, a prospective multicenter study to evaluate the efficacy of current therapeutic strategies for ocular toxoplasmosis was performed in The Netherlands and included 106 patients with active ocular toxoplasmosis. The principal conclusion of this study is that only drug therapy with pyrimethamine had any perceptible influence on any aspect of ocular toxoplasmosis, but this effect may not be worth the risk of side effects except in fovea threatening lesions.
ABSTRACT
A prospective study was conducted of 865 patients with uveitis to determine the frequency of associated systemic diseases and to assess the value of limited laboratory screening of these patients. All patients underwent a standard diagnostic protocol followed--when indicated--by special tests and procedures performed in order of likelihood ('tailored approach'). For 628 patients (73%) a specific diagnosis was established based on history, ophthalmologic examination, and laboratory and radiographic studies. A definite association with systemic disease was determined for 220 patients (26%). A relationship with a subclinical systemic disorder could be presumed in 201 cases (23%) and a well-established clinical uveitis entity without a recognisable systemic disorder was present in 207 cases (24%). For 237 patients (27%) a diagnosis could not be determined. The most frequently observed systemic diseases were sarcoidosis (7%) and HLA-B27-associated seronegative spondylarthropathies (6%). Presumed or definite toxoplasmosis was encountered in 10% of cases. HLA-B27-associated acute anterior uveitis was the most common clinical entity (17%). In the majority of cases the presence of a systemic disease was not suspected prior to eye involvement and was only recognised after the subsequent diagnostic procedures.